,imgt_cdr_matches,imgt_fw_matches,imgt_cdr_identity,imgt_fw_identity,full_identity,species,hit_name,hit_seq,hit_unit,hit_study
Abituzumab,23,75,0.8518518518518519,0.8241758241758241,0.8305084745762712,mouse,556777,QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYTKYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARFLGRGAMDYWGQGTSVTVSS,Greiff_2017_pet_mouse_3_naive_B_cell_IGHM_pet_shop_mouse_3_ERX1826002_naive_B_cell_spleen_igblastn,Greiff_2017
Afutuzumab,22,70,0.7857142857142857,0.7692307692307693,0.773109243697479,mouse,22059,QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGQGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARCVYDGSWFVYWGQGTLVTVSA,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Alacizumab,23,78,0.696969696969697,0.8571428571428571,0.8145161290322581,alpaca,5695959,EVKLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARIGENYYGSSYDAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Alemtuzumab,25,51,0.78125,0.5604395604395604,0.6178861788617886,human,2334637,DVMLVESGGGLVQPGGSLSLSCAASGFTFTDYYMSWVRQPPGKALEWLGFIRNKANGYTTEYSASVKGRFTISRDNSQSILYLQMNALRAEESATYYCARYGGTTVAAPFDYWGQGTTLTVSS,Greiff_2017_C57BL_mouse_5_naive_B_cell_IGHM_C57BL-6_mouse_5_ERX1825999_naive_B_cell_spleen_igblastn,Greiff_2017
Anrukinzumab,24,79,0.8571428571428571,0.8681318681318682,0.865546218487395,alpaca,152349,EVQLVESGGGLVKLGGSLKLSCAASGFTFSSYAMSWVRQTPGKRLEWVATISSGGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARSDGYYGGFAYWGQGTLVTVSA,Greiff_2017_pet_mouse_3_naive_B_cell_IGHM_pet_shop_mouse_3_ERX1826002_naive_B_cell_spleen_igblastn,Greiff_2017
Atezolizumab,22,71,0.8148148148148148,0.7802197802197802,0.788135593220339,alpaca,Query_110253,EVQLVESGGGLVQPGRSLKLSCAASGFTFSDYAMNWIRQAPTKGLEWVASISPSGGSTHYRDSVKGRFTIFRDVAKSTLYLQMDSLRSEDTATYYCARRNWGGFDYWGQGVMVTVSS,VanDuijn_2017_HuD-immunized_IGHG_HuD-immunized_mouse-2_igblastn_IGHG,VanDuijn_2017
Bapineuzumab,21,75,0.75,0.8241758241758241,0.8067226890756303,alpaca,Query_503660,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQVPTKGLEWVTSISSGGDNTYYRDSVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCVRQDYYSGPLDYWGQGVMVTVSS,VanDuijn_2017_DNP-immunized_IGHG_DNP-immunized_mouse-4_igblastn_IGHG,VanDuijn_2017
Bemarituzumab,20,74,0.6896551724137931,0.8131868131868132,0.7833333333333333,mouse,690946,QVQLQQSGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDGYYVKRFAYWGQGTLVTVSA,Menzel_2014_Direct_addition_DA1_iglblastn,Menzel_2014
Benralizumab,25,71,0.78125,0.7802197802197802,0.7804878048780488,mouse,254601,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREGIRYYGYDYAMDYWGQGTSVTVSS,Greiff_2017_pet_mouse_1_naive_B_cell_IGHM_pet_shop_mouse_1_ERX1826000_naive_B_cell_spleen_igblastn,Greiff_2017
Bevacizumab,28,62,0.875,0.6813186813186813,0.7317073170731707,mouse,Query_483297,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREAYYYGSSHWYFDVWGAGTTVTVSS,Collins_2015_IGHM_Mouse_sample_1_iglblastn_igblastn_IGHM,Collins_2015
Bimekizumab,23,84,0.6764705882352942,0.9230769230769231,0.856,alpaca,Query_69098,EVQLVESGGGLVQPGRSLKLSCAASGFTFSDYNMAWVRQAPKKGLEWVATISYDGSSTYYRDSVKGRFTISRDNAKSTLYLQMNSLRSEDTATYYCASSPYYYDGSYYYGWFAYWGQGTLVTVSS,VanDuijn_2017_HuD-immunized_IGHM_HuD-immunized_mouse-4_igblastn_IGHM,VanDuijn_2017
Blosozumab,19,67,0.6785714285714286,0.7362637362637363,0.7226890756302521,mouse,3687093,EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWSDPENGDTEYASKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCTTGVTTAYYFDYWGQGTTLTVSS,Greiff_2017_C57BL_mouse_2_naive_B_cell_IGHM_C57BL-6_mouse_2_ERX1825990_naive_B_cell_spleen_igblastn,Greiff_2017
Bococizumab,21,67,0.7241379310344828,0.7362637362637363,0.7333333333333333,mouse,1741673,QVQLKQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLDWIGDISPGSGSTTSNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARERPLRSYAMDYWGQGTSVTVSS,Greiff_2017_NP-HEL_mouse_5_pre-B_cell_bone_marrow_IGHM_NP-HEL_mouse_5_ERX1825965_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Brolucizumab,17,67,0.5666666666666667,0.7362637362637363,0.6942148760330579,rabbit,662588,QEQLVESGGGLVQPEGSLTLTCTASGFSFSSGYYMCWVRQAPGKGLEWIGCIDPGDVRTYYASWVNGRFTISKTSSTTVTLQMTSLTAADTATYFCAKGDDNSGWGMDLWGQGTLVTVS,Banerjee_2017_vaccination_3_4d_after_3rd-immunization_iglblastn,Banerjee_2017
Brontictuzumab,26,69,0.8666666666666667,0.7582417582417582,0.7851239669421488,mouse,1334558,QVQLKQSGAELMKPGASVKLSCKATGYTFTGYWIEWVKQRPGHGLEWIGEILPGSGRTNYNEKFKGKATFTADTSSTPAYMPLSSLTTEDSAIYYCARFGGNYGYYAMDYWGQGTSVTVSS,Greiff_2017_OVA_mouse_1_naive_B_cell_IGHM_OVA_mouse_1_ERX1826005_naive_B_cell_spleen_igblastn,Greiff_2017
Cabiralizumab,26,66,0.8387096774193549,0.7252747252747253,0.7540983606557377,mouse,673306,VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARESPYYSNLYAMDYWGQGTSVTVSS,Greiff_2017_OVA_mouse_4_naive_B_cell_IGHM_OVA_mouse_4_ERX1826017_naive_B_cell_spleen_igblastn,Greiff_2017
Camrelizumab,23,81,0.8214285714285714,0.8901098901098901,0.8739495798319328,alpaca,4440310,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISGGGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTALYYCARQLYYGNYFDYWGQGTTLTVSS,Greiff_2017_HBsAg_mouse_2_naive_B_cell_IGHM_HBsAg_mouse_2_ERX1825972_naive_B_cell_spleen_igblastn,Greiff_2017
Cantuzumab,22,79,0.7857142857142857,0.8681318681318682,0.8487394957983193,mouse,297426,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRKPYWYFDVWGAGTTVTVSS,Khan_2016_Immunized_mouse_1_Immunized_mouse_1_IM_1c_iglblastn,Khan_2016
Cergutuzumab,22,62,0.7096774193548387,0.6813186813186813,0.6885245901639344,mouse,2262371,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYVDDFKGRFAFSMETSASTAYLQINNLKNEDMATYFCARSIDYYGYVEAMDYWGQGTSVTVSS,Khan_2016_Unimmunized_mouse_1_Unimmunized_mouse_1_UM_1_iglblastn,Khan_2016
Certolizumab,23,64,0.7931034482758621,0.7032967032967034,0.725,mouse,1245607,VQRVESGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARGYGSVYYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_4_naive_B_cell_IGHM_Balb-c_mouse_4_ERX1825984_naive_B_cell_spleen_igblastn,Greiff_2017
Citatuzumab,22,68,0.8148148148148148,0.7472527472527473,0.7627118644067796,mouse,378218,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADDFKGRFAFSLEPSASTAYLQINNLNNEDTATCFCARSALRLPGDYWGQGTTLTVSS,Khan_2016_Immunized_mouse_1_Immunized_mouse_1_IM_1a_iglblastn,Khan_2016
Clazakizumab,21,64,0.7,0.7032967032967034,0.7024793388429752,rabbit,38835,QLKETGGGLVQPGGSLTLSCKASGFDISNYHMSWVRQTPGKGLEWIGVIYGSVGGTDYASWVNGRFTISSDNAQNIVALQMNSLTAADTATYFCARDDSSDWGWEFNLWGQGTLVTVS,Banerjee_2017_vaccination_2_4d_after_2nd-immunization_second-sample_iglblastn,Banerjee_2017
Clivatuzumab,25,73,0.8928571428571429,0.8021978021978022,0.8235294117647058,mouse,57010,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGFGNYGFAYWGQGTLVTVSA,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Codrituzumab,21,70,0.7777777777777778,0.7692307692307693,0.7711864406779662,mouse,3691173,VQLQQSGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGALDPETGGTAYNQKFKGKAILTADKSSSTAYMELRSLTSEDSAVYYCTRFYYGSSYDYWGQGTTLTVSS,Greiff_2017_C57BL_mouse_5_naive_B_cell_IGHM_C57BL-6_mouse_5_ERX1825999_naive_B_cell_spleen_igblastn,Greiff_2017
Cofetuzumab,24,64,0.8,0.7032967032967034,0.7272727272727273,mouse,2398102,QVQLKQSGPEVVRPGVSVKISCKGSGYTFTDYAMHWVKQSHAKSLEWIGVISTYNGNTNYNQKFKGKATNTVDNSSSTDYMELARLTSEDSAINYCARDDSYFFFYALDYWGQGTSVTVSS,Khan_2016_Unimmunized_mouse_2_Unimmunized_mouse_2_UM_2_iglblastn,Khan_2016
Concizumab,24,83,0.8,0.9120879120879121,0.8842975206611571,alpaca,3881466,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARLGGYDERDAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Crenezumab,21,80,0.75,0.8791208791208791,0.8487394957983193,alpaca,945342,EVELVESGGGLVQPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLELVATINSNGGSTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCASGIYYGYYFDYWGQGTTLTVSS,Khan_2016_Unimmunized_mouse_3_Unimmunized_mouse_3_UM_3_iglblastn,Khan_2016
Crizanlizumab,28,68,0.9032258064516129,0.7472527472527473,0.7868852459016393,mouse,Query_471694,QVQLQQSGPELVKPGALVKISCKASGYTFTSYDINWVKQRPGQGLEWIGWIYPGDGSTKYNEKFKGKATLTADKSSSTAYMQLSSLTSENSAVYFCARSGEYGNYGGAMDYWGQGTSVTVSS,Collins_2015_IGHM_Mouse_sample_2_iglblastn_igblastn_IGHM,Collins_2015
Cusatuzumab,22,70,0.7096774193548387,0.7692307692307693,0.7540983606557377,alpaca,2366561,EVKVVESGGGLVQPGGSLKLSCAASGFTFSDYYMYWVRQTPEKRLEWVAYINNGGGSTYYPDTVKGRFTISRDNAKNTLYLQMSRLKSEDTAMYYWARPAYYSNYVGYFDVWGTGTTVTVSS,Greiff_2017_NP-HEL_mouse_4_pre-B_cell_bone_marrow_IGHM_NP-HEL_mouse_4_ERX1825962_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Dacetuzumab,19,59,0.8260869565217391,0.6483516483516484,0.6842105263157895,mouse,2762204,EVQGVESGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSHGKSLEWIGRVNPNNGGTSYNQKFKGKAILTVDKSSSTAYMELRSLTSEDSAVYYCAREGYYGWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Daclizumab,24,75,0.8888888888888888,0.8241758241758241,0.8389830508474576,mouse,4965181,QVQLQQSGAELAKPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSTGYTEYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGGGNYVFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Dalotuzumab,22,69,0.8148148148148148,0.7582417582417582,0.7711864406779662,mouse,4598230,VQLQQSGPGLVKPSQSLSLTCSVTGYSITSGYYWNWIRQFPGNKLEWMGYISYDGSNNYNPSLKNRISITRDTSKNQFFLKLNSVTTEDTATYYCARSGRYVFFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Dapirolizumab,21,64,0.75,0.7032967032967034,0.7142857142857143,cow,Query_474126,QVQLKESGPGLVQSSQTLSLTCTVSGFSLTNYHVSWVRQPPGKGLEWMGGIWGDGSTNYNSALKSRLSISNDTSKSQVFLKMNSLQTEDTATYYCARDRTTRYYVLDAWGQGASVTVSS,VanDuijn_2017_HuD-immunized_IGHG_HuD-immunized_mouse-5_igblastn_IGHG,VanDuijn_2017
Demcizumab,25,70,0.8928571428571429,0.7692307692307693,0.7983193277310925,mouse,7469918,VQLQQSGPELVKTGASVKISCKASGYSFTGYYMHWVKQSHGKSLEWIGYISCYNGATSYNQKFKGKATFTVDTSSSTAYMELSSLTSEDSAVYYCARGYDYDVGMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Denintuzumab,25,69,0.78125,0.7582417582417582,0.7642276422764228,mouse,1554110,QVQLQQSGPGILQPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKRYNPALKSRLTISKDTSSNQVFLKIASVDTADTATYYCARMGLDGYYSYYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Dezamizumab,22,70,0.7096774193548387,0.7692307692307693,0.7540983606557377,mouse,3591775,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDYDYGGYYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Domagrozumab,24,77,0.8888888888888888,0.8461538461538461,0.8559322033898306,alpaca,9410985,EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCAKQDYGYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Duligotuzumab,19,71,0.6333333333333333,0.7802197802197802,0.743801652892562,alpaca,6763765,EVMLVESGGGLVQPGGSLRLSCAASGFTFSDYYMYWVRQTPEKRLEWVATISDGGSYTYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARESMVTFRYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Eculizumab,26,65,0.8387096774193549,0.7142857142857143,0.7459016393442623,mouse,683286,QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARDYYGSSPNWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Efalizumab,25,60,0.8333333333333334,0.6593406593406593,0.7024793388429752,mouse,137703,QVQLQQSGAELVRPGASVKLSCKASGYSFTSYWMNWVKQRPGQGLEWIGMIHPSDSETRLNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCARGIYYYGSSYFDYWGQGTTLTVSS,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Elotuzumab,27,81,0.84375,0.8901098901098901,0.8780487804878049,alpaca,1360034,EVQLVESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYTPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARPYGNYVGSYWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Emactuzumab,20,65,0.7407407407407407,0.7142857142857143,0.7203389830508474,mouse,2320896,VQLQQSGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPDSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARDGRGLYFDVWGTGTTVTVSS,Greiff_2017_HBsAg_mouse_5_naive_B_cell_IGHM_HBsAg_mouse_5_ERX1825979_naive_B_cell_spleen_igblastn,Greiff_2017
Emibetuzumab,21,65,0.875,0.7142857142857143,0.7478260869565218,mouse,1698300,VQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARANWLDYWGQGTTLTVSS,Greiff_2017_OVA_mouse_1_naive_B_cell_IGHM_OVA_mouse_1_ERX1826005_naive_B_cell_spleen_igblastn,Greiff_2017
Emicizumab,20,64,0.7142857142857143,0.7032967032967034,0.7058823529411765,mouse,1770159,VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSPGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARRLSYGGYLDVWGTGTTVTVSS,Greiff_2017_OVA_mouse_4_naive_B_cell_IGHM_OVA_mouse_4_ERX1826017_naive_B_cell_spleen_igblastn,Greiff_2017
Enavatuzumab,26,80,0.8666666666666667,0.8791208791208791,0.8760330578512396,mouse,4738843,EVQVVESGGGLVQPGGSMKLSCVASGFTFSSYWMSWVRQSPEKGLEWVAEIRLKSDNYATHYAESVKGKFTISRDDSKSRLYLQMNSLRAEDTGVYYCTTYYGNYDAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Enoblituzumab,23,81,0.7419354838709677,0.8901098901098901,0.8524590163934426,alpaca,2250176,EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSSTIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARGGRVIYYGSPMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Enokizumab,25,69,0.8064516129032258,0.7582417582417582,0.7704918032786885,mouse,254828,QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARPDYYGSSYVSFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Epratuzumab,21,65,0.84,0.7142857142857143,0.7413793103448276,mouse,2168739,VQLQQSGAELVRPGTSVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGVINPSDSYTNYKQKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARRDTTTFYWGQGTTLTVSS,Greiff_2017_HBsAg_mouse_5_naive_B_cell_IGHM_HBsAg_mouse_5_ERX1825980_naive_B_cell_spleen_igblastn,Greiff_2017
Eptinezumab,16,65,0.5333333333333333,0.7142857142857143,0.6694214876033058,rabbit,308247,QSLEESGGDLVKPGASLTLTCKASGFDLSSGYYMCWVRQAPGKGLEWIACIGTNSGSTYYASWAKGRFTISKTSSTTVTLQMTSLTAADTATYFCARGDGYAYGGYDLWGPGTLVTVS,Banerjee_2017_terminal_bleed_terminal_collection_spleen_iglblastn,Banerjee_2017
Etaracizumab,22,72,0.8461538461538461,0.7912087912087912,0.8034188034188035,alpaca,213219,EVQRVESGGGLVKPGGSLKLSCAASGFAFSSYDMSWVRQTPEKRLEWVAYVSSGGGSTYYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHEDGSFAYWGQGTLVTVSA,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Etrolizumab,21,56,0.7777777777777778,0.6153846153846154,0.652542372881356,mouse,2471647,DVKLQESGPGLAKPSQTLSLTCSVTGFSITSDYWTWIRKSPGNKLEYMGYISYSGSTYYNPSLKSRISITRDTSKNQYYLQLNSVTTEDTATYYCARHGSSSGYFDYWGQGTTLTVSS,Greiff_2017_C57BL_mouse_3_naive_B_cell_IGHM_C57BL-6_mouse_3_ERX1825993_naive_B_cell_spleen_igblastn,Greiff_2017
Farletuzumab,27,69,0.9,0.7582417582417582,0.7933884297520661,alpaca,4220548,EVQLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHGDDYDPAWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Fibatuzumab,24,67,0.8,0.7362637362637363,0.7520661157024794,mouse,566611,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYSNHEDFDYWGQGTTLTVSS,Greiff_2017_OVA_mouse_3_naive_B_cell_IGHM_OVA_mouse_3_ERX1826014_naive_B_cell_spleen_igblastn,Greiff_2017
Ficlatuzumab,23,74,0.8214285714285714,0.8131868131868132,0.8151260504201681,mouse,210394,QVQLQQPGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARNYYGSSIFDYWGQGTTLTVSS,Greiff_2017_NP-HEL_mouse_2_pre-B_cell_bone_marrow_IGHM_NP-HEL_mouse_2_ERX1825956_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Flotetuzumab,24,72,0.8275862068965517,0.7912087912087912,0.8,mouse,2836547,EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARSLLLRFSWFAYWGQGTLVTVSA,Greiff_2017_HBsAg_mouse_1_naive_B_cell_IGHM_HBsAg_mouse_1_ERX1825969_naive_B_cell_spleen_igblastn,Greiff_2017
Fontolizumab,21,74,0.75,0.8131868131868132,0.7983193277310925,mouse,2412787,QVQLKQPGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGLLGKPWFADWGQGTLVTVSA,Greiff_2017_OVA_mouse_4_naive_B_cell_IGHM_OVA_mouse_4_ERX1826017_naive_B_cell_spleen_igblastn,Greiff_2017
Fremanezumab,21,73,0.6774193548387096,0.8021978021978022,0.7704918032786885,mouse,4032844,EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAQIRLKSDNYATHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTAYYDYDLAWFAYWGQGTLVTVSA,Greiff_2017_HBsAg_mouse_1_naive_B_cell_IGHM_HBsAg_mouse_1_ERX1825969_naive_B_cell_spleen_igblastn,Greiff_2017
Galcanezumab,21,62,0.75,0.6813186813186813,0.6974789915966386,mouse,980456,QVQLQQSGAELVRPGTSVKMSCKASGYTFTNYWIGWAKQRPGHGLEWIGDIYPGGGYTNYNEKFKGKATLTADKSSSTAYMQFSSLTSEDSAIYYCARLSDYDGGFDYWGQGTTLTVSS,Greiff_2017_HBsAg_mouse_2_naive_B_cell_IGHM_HBsAg_mouse_2_ERX1825972_naive_B_cell_spleen_igblastn,Greiff_2017
Gatipotuzumab,24,78,0.8,0.8571428571428571,0.8429752066115702,mouse,3525685,EVQLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYATHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRHYYGSSYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Gemtuzumab,20,70,0.8,0.7692307692307693,0.7758620689655172,mouse,4190572,EVQLQQSGPELVKPGASVKISCKASGYTFTDYNMHWVKQSPGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCADGNPWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Gevokizumab,23,78,0.7931034482758621,0.8571428571428571,0.8416666666666667,human,Query_194690,QVTLKESGPGILKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARRRYDGPWFAYWGQGTLVTVSA,Collins_2015_IGHM_Mouse_sample_2_iglblastn_igblastn_IGHM,Collins_2015
Ibalizumab,27,79,0.8709677419354839,0.8681318681318682,0.8688524590163934,mouse,Query_71608,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREGGNYGAWFAYWGQGTLVTVSA,Greiff_2015_plasma_cells_IGHM_plasma_cells_iglblastn_IGHM,Greiff_2015
Idarucizumab,26,67,0.8387096774193549,0.7362637362637363,0.7622950819672131,mouse,780039,QVQLQQSGPGLVAPSQSLSITCTVSGFSLTSYGVDWVRQSPGKGLEWLGVIWGGGSTNYNSALKSRLSISKDNSKSQVYLKMNSLQTDDTAMYYCASSAYYSYYSYDPFAYWGQGTLVTVSA,Greiff_2017_pet_mouse_1_naive_B_cell_IGHM_pet_shop_mouse_1_ERX1826000_naive_B_cell_spleen_igblastn,Greiff_2017
Ifabotuzumab,24,67,0.8,0.7362637362637363,0.7520661157024794,mouse,566611,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYSNHEDFDYWGQGTTLTVSS,Greiff_2017_OVA_mouse_3_naive_B_cell_IGHM_OVA_mouse_3_ERX1826014_naive_B_cell_spleen_igblastn,Greiff_2017
Iladatuzumab,21,63,0.8076923076923077,0.6923076923076923,0.717948717948718,mouse,217129,QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCAREVGIRLDYWGQGTLVTVSA,Greiff_2014_one_mouse_one_mouse_merged_igblastn,Greiff_2014
Imgatuzumab,20,69,0.6451612903225806,0.7582417582417582,0.7295081967213115,mouse,400202,QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYSKYNQKFKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARLSDGYPYYYAMDYWGQGTSVTVSS,Greiff_2017_pet_mouse_1_naive_B_cell_IGHM_pet_shop_mouse_1_ERX1826000_naive_B_cell_spleen_igblastn,Greiff_2017
Inebilizumab,27,58,0.9,0.6373626373626373,0.7024793388429752,mouse,4151444,VQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARSGGITTVRDFDYWGQGTTLTVSS,Greiff_2017_C57BL_mouse_1_naive_B_cell_IGHM_C57BL-6_mouse_1_ERX1825987_naive_B_cell_spleen_igblastn,Greiff_2017
Inotuzumab,24,66,0.8,0.7252747252747253,0.743801652892562,mouse,Query_547106,EVQLQQSGTVLARPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGAIYPGNSDTSYNQKFKGKAKLTAVTSTSTAYMELSSLTNEDSAVYYCTREGYGNYGAWFAYWGQGTLVTVSA,Collins_2015_IGHM_Mouse_sample_2_iglblastn_igblastn_IGHM,Collins_2015
Itolizumab,23,86,0.7666666666666667,0.945054945054945,0.9008264462809917,alpaca,4438654,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRDYDGSSDYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Ixekizumab,22,64,0.7586206896551724,0.7032967032967034,0.7166666666666667,mouse,1019821,VQLQQSGPELVKPGASVKISCKASGYSFTDYNMNWVKQSPGKGLEWIGLINPNYGTTSYNQKFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCARYDYDSTGWFAYWGQGTLVTVSA,Greiff_2017_NP-HEL_mouse_4_naive_B_cell_IGHM_NP-HEL_mouse_4_ERX1825963_naive_B_cell_spleen_igblastn,Greiff_2017
Labetuzumab,23,73,0.8214285714285714,0.8021978021978022,0.8067226890756303,alpaca,3565102,EVQLQESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYTPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCATLYDGFPWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_4_naive_B_cell_IGHM_Balb-c_mouse_4_ERX1825984_naive_B_cell_spleen_igblastn,Greiff_2017
Lacnotuzumab,24,79,0.8,0.8681318681318682,0.8512396694214877,mouse,3590860,EVQLQESGPGLVKPSQSLSLTCTVTDYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARFDYDGYYYAMDYWGQGTSVTVSS,Khan_2016_Unimmunized_mouse_2_Unimmunized_mouse_2_UM_2_iglblastn,Khan_2016
Ladiratuzumab,21,70,0.7241379310344828,0.7692307692307693,0.7583333333333333,mouse,314379,EVQLQQSGAELVKPGASVKLSCTASGLNIKDYYMHWVKQRPEQGLEWIGWIDPENGDTEYAPKFQGKATMTADTSSNTAYLQLSSLTSEDTAVYYCNAQNYGYGAWFAYWGQGTLVTVSA,Menzel_2014_Ligation_method_Lig_iglblastn,Menzel_2014
Lambrolizumab,25,64,0.8333333333333334,0.7032967032967034,0.7355371900826446,mouse,415252,QVQLQQSGAELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGEINPSNGGTNFNEKFKSKATPTVDKSSSTAYMQLSSLTSEDSAVYFCARRDYRYDVGPFDYWGQGTTLTVSS,Menzel_2014_Ligation_method_Lig_iglblastn,Menzel_2014
Lampalizumab,20,73,0.6896551724137931,0.8021978021978022,0.775,mouse,4323917,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGETTYADDFKGRFAFSLDTSASTAYLQINNLKNEDMATYSCEREDSCRLTGTAYWGQGTMVTVSA,Khan_2016_Unimmunized_mouse_2_Unimmunized_mouse_2_UM_2_iglblastn,Khan_2016
Landogrozumab,18,80,0.72,0.8791208791208791,0.8448275862068966,alpaca,Query_1224804,EVQLVESGGGLVQPGRSLKLSCAASGFTFSDYNMAWVRQAPKKGLEWVASITSSGGSTYYPDSVKGRFTISRDNAKNTLYLQMNSLRSEDTATYYCARLDYGFDYWGQGTLVTVSS,VanDuijn_2017_DNP-immunized_IGHG_DNP-immunized_mouse-4_igblastn_IGHG,VanDuijn_2017
Lebrikizumab,20,65,0.7142857142857143,0.7142857142857143,0.7142857142857143,mouse,677025,QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARDGYYDPYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Lifastuzumab,18,72,0.6206896551724138,0.7912087912087912,0.75,alpaca,Query_1389,EVQLVESGGGVVQPGKSLKLSCAASGFSFSDSAMAWVRQSPKMGLEWVATIIYDGSHTFYRDSVQGRFIISRDNAKNTLYLQMDSLRSEETATYYCARHEGFYWYFDFWGPGTMVTVSS,VanDuijn_2017_DNP-immunized_IGHA_DNP-immunized_mouse-5_igblastn_IGHA,VanDuijn_2017
Ligelizumab,23,63,0.71875,0.6923076923076923,0.6991869918699187,mouse,1946233,QVQLQQPGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARFSHYYGSSYDYFDYWGQGTTLTVSS,Greiff_2017_OVA_mouse_5_pre-B_cell_bone_marrow_IGHM_OVA_mouse_5_ERX1826019_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Lintuzumab,25,71,0.78125,0.7802197802197802,0.7804878048780488,mouse,2667056,VQLQQSGAELVKPGASVKISCKASGYTFTDYNMHWVKQSHGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCARGRPKYGNYGYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Lodelcizumab,20,67,0.6451612903225806,0.7362637362637363,0.7131147540983607,mouse,3675408,VQLQQSGAELVKPGASVKLSCKASGYTFTSYYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARSLYYYGSSYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Lorvotuzumab,25,78,0.8928571428571429,0.8571428571428571,0.865546218487395,alpaca,263708,EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSSTIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARSRKGDYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Lumretuzumab,22,62,0.7333333333333333,0.6813186813186813,0.6942148760330579,mouse,2706242,QVQLQQSGAELVKPGASVKLSCKTSGFTFSSSYISWLKQKPGQSLEWIAWIYAGTGGTSYNQKFTGKAQLTVDTSSSTAYMQFSSLTTEDSAIYYCARHRDYYGSNYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Lutikizumab,22,66,0.7096774193548387,0.7252747252747253,0.7213114754098361,alpaca,5523687,EVKLQESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEGVATISDGGSYTYYPDNVKGRFTISRDNAKNNLYLQMSHLKSEDTAMYYCARGGVTTVVKGYFDVWGTGTTVTVSS,Greiff_2017_OVA_mouse_2_naive_B_cell_IGHM_OVA_mouse_2_ERX1826008_naive_B_cell_spleen_igblastn,Greiff_2017
Matuzumab,25,76,0.8333333333333334,0.8351648351648352,0.8347107438016529,mouse,1775391,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEINPSNGRTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCASVDYDYDGGYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Mepolizumab,22,67,0.7857142857142857,0.7362637362637363,0.7478991596638656,cow,7887452,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVCLKMNSLQIDDPAMYYCARDAPLLLLRLDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Milatuzumab,24,70,0.8275862068965517,0.7692307692307693,0.7833333333333333,mouse,895619,QLQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTCTGEPTYADDFKGRFAFSLETSASTAYLQLTNLKNEDTATYFCSRSRGKYWFAYWGQGTLVTVSA,Khan_2016_Immunized_mouse_1_Immunized_mouse_1_IM_1b_iglblastn,Khan_2016
Mirikizumab,19,72,0.7916666666666666,0.7912087912087912,0.7913043478260869,mouse,270908,VQLKQSGPELVKPGASVKVSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARNWDEAYWGQGTLVTVSA,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Mogamulizumab,19,78,0.6785714285714286,0.8571428571428571,0.8151260504201681,alpaca,898143,EVQLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYSYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHEDGNFHFDYWGQGTTLTVSS,Greiff_2017_HBsAg_mouse_4_naive_B_cell_IGHM_HBsAg_mouse_4_ERX1825978_naive_B_cell_spleen_igblastn,Greiff_2017
Monalizumab,28,63,0.8235294117647058,0.6923076923076923,0.728,mouse,5986340,QVQLQQSGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGGYDYDPLYWYFDVWGTGTTVTVSS,Greiff_2017_C57BL_mouse_4_naive_B_cell_IGHM_C57BL-6_mouse_4_ERX1825996_naive_B_cell_spleen_igblastn,Greiff_2017
Mosunetuzumab,25,68,0.8928571428571429,0.7472527472527473,0.7815126050420168,mouse,2551642,QVQLQQSGAELVRPGASVKLSCKASGYTFTDYYINWVKQRPGQGLEWIARIYPGSGNTYYNEKFKGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARDAYSNYYFDYWGQGTTLTVSS,Greiff_2017_NP-HEL_mouse_5_pre-B_cell_bone_marrow_IGHM_NP-HEL_mouse_5_ERX1825965_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Motavizumab,23,70,0.7419354838709677,0.7692307692307693,0.7622950819672131,human,413203,QVTLKVSGPGILQPSQTLSLTCSFSGFSLSTFGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPALKSRLTISKDTSKNQVFLKIANGDTADTATYYCARIMILYGNWYFDVWGTGTTVTVSS,Greiff_2017_NP-HEL_mouse_5_naive_B_cell_IGHM_NP-HEL_mouse_5_ERX1825966_naive_B_cell_spleen_igblastn,Greiff_2017
Natalizumab,29,69,0.90625,0.7582417582417582,0.7967479674796748,mouse,134825,VQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYAPKFQGKATITADTSSNTAYLQLSSLTSEDTAIYYCARTGYYGNYGGYAMDYWGQGTSVTVSS,Greiff_2017_pet_mouse_1_naive_B_cell_IGHM_pet_shop_mouse_1_ERX1826000_naive_B_cell_spleen_igblastn,Greiff_2017
Nemolizumab,23,65,0.7419354838709677,0.7142857142857143,0.7213114754098361,mouse,7324632,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYDCARDGYDYDGPYYLDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Nimotuzumab,21,70,0.65625,0.7692307692307693,0.7398373983739838,mouse,1117552,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSGDYDDDGRCFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Obinutuzumab,22,70,0.7857142857142857,0.7692307692307693,0.773109243697479,mouse,22059,QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGQGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARCVYDGSWFVYWGQGTLVTVSA,Greiff_2015_naive_b_IGM_naive_b_igblastn,Greiff_2015
Ocaratuzumab,24,60,0.8,0.6593406593406593,0.6942148760330579,mouse,1114550,QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARSTVVGRDWYFDVWGTGTTVTVSS,Greiff_2017_OVA_mouse_2_pre-B_cell_bone_marrow_IGHM_OVA_mouse_2_ERX1826007_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Ocrelizumab,29,59,0.90625,0.6483516483516484,0.7154471544715447,mouse,1654076,QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARNLYYSNRSYWYFDVWGTGTTVTVSS,Greiff_2017_C57BL_mouse_4_pre-B_cell_bone_marrow_IGHM_C57BL-6_mouse_4_ERX1825995_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Olendalizumab,23,64,0.696969696969697,0.7032967032967034,0.7016129032258065,mouse,2331178,VQLQQSGPELVKPGASVKISCKASGYTFTDYSMNWVKQSHGKSLEWIGDINPNTGGTSYNQKFKGKATLNVDKSSSTAYMELRSLTSEDSAVYYCARGSYDGYYVYYYAMDYWGQGTSVTVSS,Greiff_2017_NP-HEL_mouse_2_naive_B_cell_IGHM_NP-HEL_mouse_2_ERX1825957_naive_B_cell_spleen_igblastn,Greiff_2017
Olokizumab,19,68,0.5588235294117647,0.7472527472527473,0.696,human,3793064,EVQLVESGGGLVQPGGSLRLSCATSGFTFTDYYMSWVRQPPGKALEWLGFIRNKANGYTTEYSASVKGRFTISRDNSQSILYLQMNTLRAEDSATYYCARESYYGHLREGFFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Omalizumab,23,61,0.71875,0.6703296703296703,0.6829268292682927,mouse,1075694,EVQLQESGPGLVKPSQSLSLTCSVTGYSITSGYYWNWIRQFPGNKLEWMGYISYDGSNNYNPSLKNRISITRDTSKNQFFLKLNSVTTEDTATYYCARGSHYYGSRHWYFDVWGTGTTVTVSS,Greiff_2017_C57BL_mouse_4_pre-B_cell_bone_marrow_IGHM_C57BL-6_mouse_4_ERX1825995_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Onartuzumab,23,57,0.8214285714285714,0.6263736263736264,0.6722689075630253,mouse,10709432,QVQLQQSGPELVRPGASVKMSCTASGYTFTSYWMHWVKQRPGQGLEWIGMIDPSNSETRLNQKFKDKATLNVDKSSNTAYMQLSSLTSEDSAVYYCATARATPLDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Oportuzumab,22,68,0.8148148148148148,0.7472527472527473,0.7627118644067796,mouse,378218,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADDFKGRFAFSLEPSASTAYLQINNLNNEDTATCFCARSALRLPGDYWGQGTTLTVSS,Khan_2016_Immunized_mouse_1_Immunized_mouse_1_IM_1a_iglblastn,Khan_2016
Otlertuzumab,23,61,0.8846153846153846,0.6703296703296703,0.717948717948718,mouse,105029,EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGTSYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSDGNPFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Ozanezumab,20,75,0.8,0.8241758241758241,0.8189655172413793,mouse,1884988,QVQLQQSGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCELELGRTGYWGQGTTLTVSS,Greiff_2017_NP-HEL_mouse_1_naive_B_cell_IGHM_NP-HEL_mouse_1_ERX1825952_naive_B_cell_spleen_igblastn,Greiff_2017
Palivizumab,26,73,0.8666666666666667,0.8021978021978022,0.8181818181818182,human,246185,QVTLKVSGPGLLKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARSMITTHWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Parsatuzumab,26,59,0.8125,0.6483516483516484,0.6910569105691057,mouse,Query_1821150,VQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAREDVYYDYDDYAMDYWGQGTSVTGSS,Greiff_2017_HBsAg_mouse_2_PC_IGHM_IGHG_IGHM_HBsAg_mouse_2_ERX1825970_long_lived_plasma_cell_bone_marrow_iglblastn_IGHM,Greiff_2017
Pateclizumab,23,61,0.8214285714285714,0.6703296703296703,0.7058823529411765,mouse,6095589,VQLKESGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARPTMITPWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Pembrolizumab,25,64,0.8333333333333334,0.7032967032967034,0.7355371900826446,mouse,415252,QVQLQQSGAELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGEINPSNGGTNFNEKFKSKATPTVDKSSSTAYMQLSSLTSEDSAVYFCARRDYRYDVGPFDYWGQGTTLTVSS,Menzel_2014_Ligation_method_Lig_iglblastn,Menzel_2014
Perakizumab,26,78,0.8387096774193549,0.8571428571428571,0.8524590163934426,alpaca,4075231,EVQLVESGGGLVKPGGSLKLSCAASGFTFSDYYMYWVRQTPEKRLEWVATISDGGSYTYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARDRDYGSSYGAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Pertuzumab,21,59,0.75,0.6483516483516484,0.6722689075630253,mouse,4831670,EVQLQESGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARNYGSSFYFDYWGQGTTLTVSS,Greiff_2017_HBsAg_mouse_1_naive_B_cell_IGHM_HBsAg_mouse_1_ERX1825969_naive_B_cell_spleen_igblastn,Greiff_2017
Pidilizumab,21,71,0.7777777777777778,0.7802197802197802,0.7796610169491526,mouse,300459,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYSGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCVRVGYNGTMDYWGQGTSVTVSS,Khan_2016_Immunized_mouse_4_Immunized_mouse_4_S1_iglblastn,Khan_2016
Pinatuzumab,26,61,0.896551724137931,0.6703296703296703,0.725,mouse,1866682,VQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDGSSYDWYFDVWGTGTTVTVSS,Greiff_2017_NP-HEL_mouse_5_naive_B_cell_IGHM_NP-HEL_mouse_5_ERX1825966_naive_B_cell_spleen_igblastn,Greiff_2017
Plozalizumab,19,76,0.5588235294117647,0.8351648351648352,0.76,alpaca,Query_35723,VQLVESGGGLVQPKESLKISCAASGFTFSNAAMYWVRQAPGKGLEWVARIRTKPNNYATYYADSVKGRFTISRDDSKSTLYLQMDSLRSEDTATYYCTTDYVYYGLLRRGFAYWGQGTLVTFSS,VanDuijn_2017_HuD-immunized_IGHG_HuD-immunized_mouse-5_igblastn_IGHG,VanDuijn_2017
Pogalizumab,19,57,0.6785714285714286,0.6263736263736264,0.6386554621848739,mouse,807170,LQLKESGPELVEPGASMKMSCKASGYTFTDSYMKGVRQSHGKSLEWIGDIYPKNGDTFYNQKFKDKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVMGLRLYWYFDVWGAGTTVTVSS,Greiff_2014_9_mice_nine_mice_merged_igblastn,Greiff_2014
Polatuzumab,21,63,0.8076923076923077,0.6923076923076923,0.717948717948718,mouse,217129,QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCAREVGIRLDYWGQGTLVTVSA,Greiff_2014_one_mouse_one_mouse_merged_igblastn,Greiff_2014
Ponezumab,16,66,0.5714285714285714,0.7252747252747253,0.6890756302521008,mouse,459836,VQLKQSGAELVKPGASVKLSCKASGYTFTSYYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCASPYYYGSSPDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Prasinezumab,22,78,0.8148148148148148,0.8571428571428571,0.847457627118644,alpaca,Query_884785,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQTPTKGLEWVASISTGGGNTYYRDSVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCARHGATEGIDYWGQGTLVTVSS,VanDuijn_2017_HuD-immunized_IGHG_HuD-immunized_mouse-2_igblastn_IGHG,VanDuijn_2017
Quilizumab,23,80,0.8846153846153846,0.8791208791208791,0.8803418803418803,alpaca,4316237,EVQLVESGGGLVQPGGSLKLSCAASGFTFSDYGMAWVRQAPRKGPEWVAFISNLAYSIYYADTVTGRFTISRENAKNTLYLEMSSLRSEDTAMYYCARHNWDAMDYWGQGTSVTVSS,Greiff_2017_C57BL_mouse_2_naive_B_cell_IGHM_C57BL-6_mouse_2_ERX1825990_naive_B_cell_spleen_igblastn,Greiff_2017
Ralpancizumab,21,74,0.65625,0.8131868131868132,0.7723577235772358,mouse,1473363,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEINPSNGRTNYNEKFKSKATMTVDKSSSTAYMQLSSLTSEDSAVYYCARSRPLVRLPDYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_4_naive_B_cell_IGHM_Balb-c_mouse_4_ERX1825984_naive_B_cell_spleen_igblastn,Greiff_2017
Ranibizumab,26,62,0.8125,0.6813186813186813,0.7154471544715447,mouse,Query_483297,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREAYYYGSSHWYFDVWGAGTTVTVSS,Collins_2015_IGHM_Mouse_sample_1_iglblastn_igblastn_IGHM,Collins_2015
Ravulizumab,24,65,0.7741935483870968,0.7142857142857143,0.7295081967213115,mouse,683286,QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARDYYGSSPNWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Refanezumab,27,73,0.7105263157894737,0.8021978021978022,0.7751937984496124,mouse,1873184,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRGINYYGSSQISSYYYAMDYWGQGTSVTVSS,Khan_2016_Immunized_mouse_4_Immunized_mouse_4_S2_iglblastn,Khan_2016
Reslizumab,23,68,0.8846153846153846,0.7472527472527473,0.7777777777777778,human,Query_1148227,QVQLKESGPGLVQPSQTLSLTCTVSGLSLTSNSVSWIRQPPGKGLEWMGVIWSNGGTDYNSAIKSRLVISRDTSKSQVFLKMNSLQAEDTAMYFCARIYYGGYFDYWGQGVMVTVSS,VanDuijn_2017_HuD-immunized_IGHD_HuD-immunized_mouse-2_igblastn_IGHD,VanDuijn_2017
Risankizumab,24,71,0.8275862068965517,0.7802197802197802,0.7916666666666666,mouse,1438325,QVQLQQSDAELVKPGASVKISCKVSGYTFTDHTIHWMKQRPEQGLEWIGYIYPRDGSTKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDYAVYFCAIPDSSGYAWFAYWGQGTLVTVSA,Greiff_2017_HBsAg_mouse_2_pre-B_cell_bone_marrow_IGHM_HBsAg_mouse_2_ERX1825971_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Rivabazumab,22,77,0.6111111111111112,0.8461538461538461,0.7795275590551181,alpaca,Query_206051,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQAPTKGLEWVATISYDGSSTYYRDSVKGRFTISRDNAKSTLYLQMNSLRSEDTATYYCTRDRRHIYYYSGDYYYVMDAWGQGASVTVSS,VanDuijn_2017_HuD-immunized_IGHD_HuD-immunized_mouse-2_igblastn_IGHD,VanDuijn_2017
Romosozumab,27,65,0.84375,0.7142857142857143,0.7479674796747967,mouse,2048535,VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYYARLGYDSSYEDWYFDVWGTGTTVTVSS,Greiff_2017_NP-HEL_mouse_5_pre-B_cell_bone_marrow_IGHM_NP-HEL_mouse_5_ERX1825965_pre-B_cell_bone_marrow_igblastn,Greiff_2017
Rontalizumab,19,54,0.6785714285714286,0.5934065934065934,0.6134453781512605,mouse,683301,VQLQQSGPELVKPGASVKMSCKASGYTFTNYIMHWVKQKPGQGLEWIGYINPYNDGTKYNENFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCASWIEVRRFMDYWGQGTSVTVSS,Khan_2016_Immunized_mouse_2_Immunized_mouse_2_IM_2_iglblastn,Khan_2016
Rosmantuzumab,19,69,0.7307692307692307,0.7582417582417582,0.7521367521367521,mouse,59520,QVQLQQSGPELVKPGASVKISCKASGYTFTDYYINWVKQRPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYFCATYYSNNFDYWGQGTTLTVSS,Greiff_2017_OVA_mouse_2_naive_B_cell_IGHM_OVA_mouse_2_ERX1826011_naive_B_cell_spleen_igblastn,Greiff_2017
Rovalpituzumab,24,62,0.8571428571428571,0.6813186813186813,0.7226890756302521,mouse,Query_359677,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREGDSTGPFDYWGQGTTLTVSS,Collins_2015_IGHM_Mouse_sample_2_iglblastn_igblastn_IGHM,Collins_2015
Ruplizumab,22,83,0.7333333333333333,0.9120879120879121,0.8677685950413223,mouse,4369353,QVQLKQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSDYRYDVNAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Sacituzumab,28,73,0.9333333333333333,0.8021978021978022,0.8347107438016529,mouse,124441,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRGYGSSYWYFDVWGAGTTVTVSS,Khan_2016_Unimmunized_mouse_2_Unimmunized_mouse_2_UM_2_iglblastn,Khan_2016
Samalizumab,22,69,0.7857142857142857,0.7582417582417582,0.7647058823529411,mouse,7037719,VQLQQTGPELVKPGASVKISCKASGYSFTDYIMLWVKQSHGKSLEWIGNINPYYGSTSYNLKFKGKATLTVDKSSSTAYMQLNSLTSEDSAVYYCARSGRYEDYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Sapelizumab,21,62,0.7241379310344828,0.6813186813186813,0.6916666666666667,mouse,2961449,EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Satralizumab,21,62,0.7241379310344828,0.6813186813186813,0.6916666666666667,mouse,2961449,EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Simtuzumab,23,77,0.92,0.8461538461538461,0.8620689655172413,mouse,3925394,VQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSTSTAYMQLSSLTSEDTAVYFCARNWENFDYWGQGSTLTVSS,Greiff_2017_NP-HEL_mouse_5_naive_B_cell_IGHM_NP-HEL_mouse_5_ERX1825966_naive_B_cell_spleen_igblastn,Greiff_2017
Sofituzumab,22,61,0.7586206896551724,0.6703296703296703,0.6916666666666667,mouse,3404941,VQLKESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARWTGTYGDGLDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_4_naive_B_cell_IGHM_Balb-c_mouse_4_ERX1825984_naive_B_cell_spleen_igblastn,Greiff_2017
Solanezumab,18,77,0.72,0.8461538461538461,0.8189655172413793,alpaca,85793,VQLVESGGGLVQPGGSLRLSCAASGFTFSRYAMSWVRQAPGKGLEWVSAINSVGSSTYVVDSVKGRFTISRDNAKNTLYLQLSSLKTEDTAIYYCARGLGRVDYWGQGTQVTVS,Li_2017_NO1camel_NO1camel_iglblastn,Li_2017
Spartalizumab,20,64,0.7692307692307693,0.7032967032967034,0.717948717948718,mouse,5893598,QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSGSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRGTTATGAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Suvizumab,24,71,0.8275862068965517,0.7802197802197802,0.7916666666666666,mouse,863983,QVQLQQSGAELVRPGTSVKISCKASGYTFTNYWLGWVKQRPGHGLEWIGDIYPGGGYTNYNEKFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCARGIYGNFYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Tadocizumab,27,72,0.9642857142857143,0.7912087912087912,0.8319327731092437,mouse,169882,QVQLKESGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARRDGNYGWFAYWGQGTLVTVSA,Greiff_2014_one_mouse_one_mouse_merged_igblastn,Greiff_2014
Talacotuzumab,23,58,0.7931034482758621,0.6373626373626373,0.675,mouse,9233333,VQLQQSGPELVKPGASVKMSCKASGYTFTDYYMKWVKQSHGKSLEWIGVINPNNGDTFYNQKFKGKATLTVDKSSSTAYMQLDSLTSEDSAVYYCARSSLLRPSWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Tanezumab,24,66,0.8,0.7252747252747253,0.743801652892562,mouse,1520534,QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARGGYYYGSSYYFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Telisotuzumab,21,61,0.7777777777777778,0.6703296703296703,0.6949152542372882,mouse,5217679,VQLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQSHGKSLEWIGGINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSEITTVFDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_3_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_3_ERX1825983_naive_B_cell_spleen_igblastn,Greiff_2017
Teplizumab,23,59,0.8214285714285714,0.6483516483516484,0.6890756302521008,mouse,766994,QVQLQQSGAELARPGASVKMSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPSSGYTNYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARYYDDYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Tibulizumab,25,81,0.7575757575757576,0.8901098901098901,0.8548387096774194,rhesus,291823,QVQLQESGPGLVKPSETLSLTCAVSGGSFSGYYWGWIRQPPGKGLEWIGYISGSSGSTDYNPSLKSRVTISTDTSKNQFSLKLSSVTAADTAVYYCARSYYNIWTGYYTHFDYWGQGVLVTVSS,Sundling_2014_IGHV4_IGHV4_iglblastn,Sundling_2014
Tigatuzumab,25,81,0.8928571428571429,0.8901098901098901,0.8907563025210085,alpaca,8705068,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRGSTMITTDYWGQGTTLTVSS,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Tildrakizumab,23,68,0.8846153846153846,0.7472527472527473,0.7777777777777778,mouse,2030585,QVQLQQSGPELVRPGASVKLSCKASGYIFITYWMNWVKQRPGQGLEWIGQIFPASGSTNYNEMFEGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYQGFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Timigutuzumab,24,60,0.7741935483870968,0.6593406593406593,0.6885245901639344,mouse,4510474,EVKLMESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARGGGDGYPFYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Tislelizumab,24,68,0.8888888888888888,0.7472527472527473,0.7796610169491526,mouse,6072526,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARAYGNYWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Tocilizumab,24,68,0.8275862068965517,0.7472527472527473,0.7666666666666667,mouse,2961449,EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Trastuzumab,24,60,0.7741935483870968,0.6593406593406593,0.6885245901639344,mouse,4510474,EVKLMESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARGGGDGYPFYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Tregalizumab,24,71,0.7272727272727273,0.7802197802197802,0.7661290322580645,mouse,3240166,VQLVETGGGLVRPGNSLKLSCVTSGFTFSNYRMHWLRQPPGKRLEWIAVITVKSDNYGANYAESVKGRFTISRDDSKSSVYLQMNRLREEDTATYYCSRGGYRYDAGAWFAYWGQGTLVTVSA,Greiff_2017_Balb_mouse_1_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_1_ERX1825981_naive_B_cell_spleen_igblastn,Greiff_2017
Vandortuzumab,29,65,0.8787878787878788,0.7142857142857143,0.7580645161290323,mouse,2440684,VQLKESGPGLVKPSQSLSLTCTVSGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSRPYDYDGYYYAMDYWGQGTSVTVSS,Khan_2016_Unimmunized_mouse_1_Unimmunized_mouse_1_UM_1_iglblastn,Khan_2016
Vanucizumab,27,61,0.7105263157894737,0.6703296703296703,0.6821705426356589,mouse,7865783,VQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDTSSSTAYMELRCLTSEDSAFYYCARSPNPSYCDGSSYEGYFDVWGTGTTVTVSS,Greiff_2017_C57BL_mouse_2_naive_B_cell_IGHM_C57BL-6_mouse_2_ERX1825990_naive_B_cell_spleen_igblastn,Greiff_2017
Vatelizumab,24,73,0.7741935483870968,0.8021978021978022,0.7950819672131147,mouse,3230480,VQLQESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARANDGYYADYYAMDYWGQGTSVTVSS,Greiff_2017_Balb_mouse_4_naive_B_cell_IGHM_Balb-c_mouse_4_ERX1825984_naive_B_cell_spleen_igblastn,Greiff_2017
Vedolizumab,26,73,0.8666666666666667,0.8021978021978022,0.8181818181818182,mouse,1737582,QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLEWIGEIDPSDSYTNYNQKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYDGEDYAMDYWGQGTSVTVSS,Greiff_2017_NP-HEL_mouse_2_naive_B_cell_IGHM_NP-HEL_mouse_2_ERX1825957_naive_B_cell_spleen_igblastn,Greiff_2017
Veltuzumab,27,77,0.84375,0.8461538461538461,0.8455284552845529,mouse,1589330,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSAYYGSSGYWYFDVWGAGTTVTVSS,Greiff_2017_Balb_mouse_2_naive_B_cell_IGHM_naive_B_cell_IGHM_Balb-c_mouse_2_ERX1825982_naive_B_cell_spleen_igblastn,Greiff_2017
Visilizumab,26,76,0.896551724137931,0.8351648351648352,0.85,mouse,855759,QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYTKYNQKFKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARSAYYDYDGFAYWGQGTLVTVSA,Greiff_2017_HBsAg_mouse_2_naive_B_cell_IGHM_HBsAg_mouse_2_ERX1825972_naive_B_cell_spleen_igblastn,Greiff_2017
Vonlerolizumab,19,57,0.6785714285714286,0.6263736263736264,0.6386554621848739,mouse,807170,LQLKESGPELVEPGASMKMSCKASGYTFTDSYMKGVRQSHGKSLEWIGDIYPKNGDTFYNQKFKDKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVMGLRLYWYFDVWGAGTTVTVSS,Greiff_2014_9_mice_nine_mice_merged_igblastn,Greiff_2014
Vorsetuzumab,25,64,0.8928571428571429,0.7032967032967034,0.7478991596638656,mouse,217137,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARDVGYLYGMDYWGQGTSVTVSS,Khan_2016_Immunized_mouse_4_Immunized_mouse_4_S2_iglblastn,Khan_2016
Vunakizumab,28,62,0.875,0.6813186813186813,0.7317073170731707,mouse,8172717,VQVVESGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGAIDPGTGGTDYNQKFKGKAILTADKSSSPAYLELRSLTSEDSAVYYCTRYPTHYGSSPYAMDYWGQGTSVTVSS,Greiff_2017_C57BL_mouse_5_naive_B_cell_IGHM_C57BL-6_mouse_5_ERX1825999_naive_B_cell_spleen_igblastn,Greiff_2017
Xentuzumab,19,73,0.7307692307692307,0.8021978021978022,0.7863247863247863,alpaca,Query_832849,EVQLVESGGGLVQPGRSLKLSCVASGFTFTYYYMTWIRQAPRKGLEWVASITNTGSVTYYGDSVKSRFTISRDNAKSTLYLQMNSLRSEDTATYYCARIMYTHFDYWGQGVMVTVSS,VanDuijn_2017_HuD-immunized_IGHG_HuD-immunized_mouse-5_igblastn_IGHG,VanDuijn_2017
Zenocutuzumab,25,61,0.7575757575757576,0.6703296703296703,0.6935483870967742,mouse,64178,EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDYGSRSYWYFDVWGTGTTVTVSS,Greiff_2017_HBsAg_mouse_5_naive_B_cell_IGHM_HBsAg_mouse_5_ERX1825979_naive_B_cell_spleen_igblastn,Greiff_2017
